Cargando…

Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults

BACKGROUND: Herring roe is an underutilized source of n-3 polyunsaturated fatty acids (PUFAs) for human consumption with high phospholipid (PL) content. Studies have shown that PL may improve bioavailability of n-3 PUFAs. Arctic Nutrition’s herring roe product MOPL™30 is a PL: docosahexaenoic acid (...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjørndal, Bodil, Strand, Elin, Gjerde, Jennifer, Bohov, Pavol, Svardal, Asbjørn, Diehl, Bernd WK, Innis, Sheila M, Berger, Alvin, Berge, Rolf K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038089/
https://www.ncbi.nlm.nih.gov/pubmed/24886291
http://dx.doi.org/10.1186/1476-511X-13-82
_version_ 1782318326604627968
author Bjørndal, Bodil
Strand, Elin
Gjerde, Jennifer
Bohov, Pavol
Svardal, Asbjørn
Diehl, Bernd WK
Innis, Sheila M
Berger, Alvin
Berge, Rolf K
author_facet Bjørndal, Bodil
Strand, Elin
Gjerde, Jennifer
Bohov, Pavol
Svardal, Asbjørn
Diehl, Bernd WK
Innis, Sheila M
Berger, Alvin
Berge, Rolf K
author_sort Bjørndal, Bodil
collection PubMed
description BACKGROUND: Herring roe is an underutilized source of n-3 polyunsaturated fatty acids (PUFAs) for human consumption with high phospholipid (PL) content. Studies have shown that PL may improve bioavailability of n-3 PUFAs. Arctic Nutrition’s herring roe product MOPL™30 is a PL: docosahexaenoic acid (DHA)-rich fish oil mixture, with a DHA:eicosapentaenoic acid (EPA) ratio of about 3:1, which is also rich in choline. In this pilot study, we determined if MOPL30 could favorably affect plasma lipid parameters and glucose tolerance in healthy young adults. METHODS: Twenty female and one male adults, between 22 and 26 years of age, participated in the study. Participants took encapsulated MOPL30, 2.4 g/d EPA + DHA, for 14 days, and completed a three-day weighed food record before and during the capsule intake. Plasma lipids and their fatty acid (FA) composition, plasma and red blood cell (RBC) phosphatidylcholine (PC) FA composition, acylcarnitines, choline, betaine and insulin were measured before and after supplementation (n = 21), and one and four weeks after discontinuation of supplementation (n = 14). An oral glucose tolerance test was performed before and after supplementation. RESULTS: Fasting plasma triacylglycerol and non-esterified fatty acids decreased and HDL-cholesterol increased after 14 days of MOPL30 intake (p < 0.05). The dietary records showed that PUFA intake prior to and during capsule intake was not different. Fasting plasma glucose was unchanged from before to after supplementation. However, during oral glucose tolerance testing, blood glucose at both 10 and 120 min was significantly lower after supplementation with MOPL30 compared to baseline measurements. Plasma free choline and betaine were increased, and the n-6/n-3 polyunsaturated (PUFA) ratio in plasma and RBC PC were decreased post-supplementation. Four weeks after discontinuation of MOPL30, most parameters had returned to baseline, but a delayed effect was observed on n-6 PUFAs. CONCLUSIONS: Herring roe rich in PL improved the plasma lipid profile and glycemic control in young adults with an overall healthy lifestyle.
format Online
Article
Text
id pubmed-4038089
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40380892014-05-30 Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults Bjørndal, Bodil Strand, Elin Gjerde, Jennifer Bohov, Pavol Svardal, Asbjørn Diehl, Bernd WK Innis, Sheila M Berger, Alvin Berge, Rolf K Lipids Health Dis Research BACKGROUND: Herring roe is an underutilized source of n-3 polyunsaturated fatty acids (PUFAs) for human consumption with high phospholipid (PL) content. Studies have shown that PL may improve bioavailability of n-3 PUFAs. Arctic Nutrition’s herring roe product MOPL™30 is a PL: docosahexaenoic acid (DHA)-rich fish oil mixture, with a DHA:eicosapentaenoic acid (EPA) ratio of about 3:1, which is also rich in choline. In this pilot study, we determined if MOPL30 could favorably affect plasma lipid parameters and glucose tolerance in healthy young adults. METHODS: Twenty female and one male adults, between 22 and 26 years of age, participated in the study. Participants took encapsulated MOPL30, 2.4 g/d EPA + DHA, for 14 days, and completed a three-day weighed food record before and during the capsule intake. Plasma lipids and their fatty acid (FA) composition, plasma and red blood cell (RBC) phosphatidylcholine (PC) FA composition, acylcarnitines, choline, betaine and insulin were measured before and after supplementation (n = 21), and one and four weeks after discontinuation of supplementation (n = 14). An oral glucose tolerance test was performed before and after supplementation. RESULTS: Fasting plasma triacylglycerol and non-esterified fatty acids decreased and HDL-cholesterol increased after 14 days of MOPL30 intake (p < 0.05). The dietary records showed that PUFA intake prior to and during capsule intake was not different. Fasting plasma glucose was unchanged from before to after supplementation. However, during oral glucose tolerance testing, blood glucose at both 10 and 120 min was significantly lower after supplementation with MOPL30 compared to baseline measurements. Plasma free choline and betaine were increased, and the n-6/n-3 polyunsaturated (PUFA) ratio in plasma and RBC PC were decreased post-supplementation. Four weeks after discontinuation of MOPL30, most parameters had returned to baseline, but a delayed effect was observed on n-6 PUFAs. CONCLUSIONS: Herring roe rich in PL improved the plasma lipid profile and glycemic control in young adults with an overall healthy lifestyle. BioMed Central 2014-05-17 /pmc/articles/PMC4038089/ /pubmed/24886291 http://dx.doi.org/10.1186/1476-511X-13-82 Text en Copyright © 2014 Bjørndal et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bjørndal, Bodil
Strand, Elin
Gjerde, Jennifer
Bohov, Pavol
Svardal, Asbjørn
Diehl, Bernd WK
Innis, Sheila M
Berger, Alvin
Berge, Rolf K
Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_full Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_fullStr Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_full_unstemmed Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_short Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_sort phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038089/
https://www.ncbi.nlm.nih.gov/pubmed/24886291
http://dx.doi.org/10.1186/1476-511X-13-82
work_keys_str_mv AT bjørndalbodil phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults
AT strandelin phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults
AT gjerdejennifer phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults
AT bohovpavol phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults
AT svardalasbjørn phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults
AT diehlberndwk phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults
AT innissheilam phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults
AT bergeralvin phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults
AT bergerolfk phospholipidsfromherringroeimproveplasmalipidsandglucosetoleranceinhealthyyoungadults